4//SEC Filing
REED ELIZABETH E 4
Accession 0001415889-25-002004
CIK 0001438533other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 8:37 PM ET
Size
5.3 KB
Accession
0001415889-25-002004
Insider Transaction Report
Form 4
REED ELIZABETH E
Chief Legal Officer and GC
Transactions
- Sale
Common Stock
2025-01-22$19.46/sh−2,437$47,424→ 76,933 total
Footnotes (2)
- [F1]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F2]Includes 737 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 29, 2024.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001283303
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 8:37 PM ET
- Size
- 5.3 KB